ALS TDI News
Recent ALS TDF News
ALS TDI storms Manhattan - Join us for an Evening with the Stars!
3/27/2008
Key database being created using samples collected by patients at ALS TDI
2/8/2008
How does ALS TDI decide which drugs and therapeutics to test?
2/8/2008
Researchers offer insight into why so many ALS drugs failed in clinical trials.
1/21/2008
Scientists discover why animal studies may lead to ineffective ALS drugs and recommend guidelines for using leading mouse model of ALS in the first paper published by ALS TDI. ALS TDI to work with Aptagen on developing "molecular bullets" for ALS
1/7/2008
From the ALS Forum: Lithium, Statins and the Toronto Conference
1/7/2008
From the ALS Forum: Lithium, Cholesterol and Statins
12/7/2007
John McCarty, Ph.D. provides a quick introduction to these two topics that are currently being heavily discussed in our ALS Forum. A story out of Italy prompted the discussed on lithium as a potential treatment for and presentations at last weeks ALS/MND Conference in Toronot, Canada continue to raise interest and questions alike concerning Cholesterol and Statins as potential treatments. Matching Gifts: Get your End of the Year Donation Doubled!
12/7/2007
ALS TDI Partners with It’s Just Lunch to Fund ALS Research
11/27/2007
Membership Program Aims to Recognize 30,000 ALS Patients
11/15/2007
Through the purchase of four different types of membership, all patients in the United States living today will be recognized as part of ALS TDI's research program. Leadership Summit Brings Top Researchers and Patients Together
11/5/2007
The conversation led the group through several potential therapeutic approached being investigated at ALS TDI - the world's largest and leading ALS reserach center. ALS TDI Opens its Doors to Patients Like Never Before
11/4/2007
ALS patients were treated to a rarity in medical research, the opportunity to meet the people actually doing the work. Nearly the entire research team of 30 people at ALS TDI provided demonstrations and answered questions to put their work in context for the ALS patient today ALS Researchers to Share Ideas with Patients at 2007 ALS TDI Leadership Summit & Open House in Boston
10/12/2007
 Meet the largest team of scientists working on ALS in the world today. Special guests include Dale Lange, Ph.D. of Mt. Sinai Hospital, Hans Keirstead, Ph.D. of the California Stem Cell Institute, Raymond Onders, M.D. of University Hospitals of Cleveland and Sharon Hesterlee, Ph.D. of the MDA. Revamped ALS 101 To Travel to Three Cities this Fall
7/24/2007
 ALS TDI President, Sean Scott, and Treatment Investigator, John McCarty, Ph.D., to host open discussions directly with ALS patients about research. ALS Research 101, an educational seminar, in three cities this fall: San Francisco,CA - Charlotte, NC, Cambridge, MA. Spring 2007 Newsletter Online Now
5/22/2007
Learn about our research efforts and meet our newest scientists in this quarter's newsletter. TDF IS NOW TDI - Collaboration Funds Historic $36M ALS Drug Search
1/16/2007
The Muscular Dystrophy Association (MDA), through its Augie’s Quest initiative, and the ALS Therapy Development Institute today announced they are establishing the world’s largest research program dedicated to discovering drugs to treat amyotrophic lateral sclerosis — ALS, or Lou Gehrig’s disease.
Part2: ALS TDI Completes Gene Expression Profile of Lou Gehrig’s Disease in Mice
10/2/2007
“This dataset is the foundation that will enable scientists at ALS TDI to understand the biological mechanisms associated with disease progression,” said Steve Perrin, Ph.D., chief scientific officer of ALS TDI. The second phase, profiling of human samples, is scheduled for completion by February of 2008. Part 1: ALS TDI Completes Gene Expression Profile of Lou Gehrig’s Disease in Mice
10/1/2007
ALS TDI has achieved a significant milestone in its ambitious science plan to understand ALS at the protein and gene level by the successful generation of the world’s largest transcriptome profiling database for the ALS mouse. The database contains complex information that details the development of the disease in the mouse at the cellular level. The data offers researchers insights into the disease process never before possible. 2006 ALS/MND Yokohama Meeting Report
1/16/2007
The Motor Neurone Disease Association’s 17th Annual International Symposium on ALS/MND was held last month (Dec. ’06) in Yokohama, Japan and is the major conference in the world on topics of research, treatment and care in ALS. This year, two of our research staff – Sean Scott and Jerry De Zutter – made significant contributions through presentations, in addition to our usual efforts with a team of researchers to understand the current developments and trends in ALS research. Mass Spectrometry Core at ALS TDF
3/24/2006
ALS TDF recently added a new Mass Spectrometry Core to our lab, and hired veteran scientist Dr. Nels Mahle to run it. ALS TDI Results Well Received at the Yokohama ALS/MND Conference
12/19/2006
As usual, ALS TDI sent a team of researchers to attend the lectures and to meet with other scientists and clinicians (our collective impressions will be posted as a report in the next weeks). This year, however, two of our researchers – Sean Scott and Jerry De Zutter – also made significant presentations as part of session 7A: Interpretation of Data from SOD1 Models. Need an Answer? Ask Our New Treatment Investigator
3/24/2006
Dr. John McCarty's job is to know about every new ALS treatment idea - and get to the bottom of it. ALS Implant Allows Brain Computer Control
10/16/2006
Stephen Heywood, brother of ALS TDF (now ALS TDI) Founder Jamie Heywood, has enrolled in a clinical trial by Cyberkinetics to test the safety and capability of a neural implant to allow communication and computer control by recording directly from the motor cortex. Letter from the Director
3/24/2006
We’re launching a new discovery research program that will let us dissect ALS piece by piece, gene by gene and protein by protein. Combined with our therapeutic development program, we will evaluate comprehensively each potential target until we find one or several that truly impacts ALS. So Much So Fast Update
7/1/2007
The documentary, which debuted at the Sundance Film Festival in 2006, has been seen by millions of people worldwide via public broadcasting stations. "So Much So Fast" offers a window into the Heywood family’s battle against ALS and the birth of ALS TDF (now the ALS Therapy Development Institute). EGCG (Green Tea Extract)
7/31/2006
ALS TDF tested EGCG in response to a report of efficacy in mice in another lab. The results are now in. TDI Launches New Mouse Study Approach
5/31/2006
ALS TDI began a major research initiative recently to understand the molecular mechanism at play in the ALS mouse – the changes in the RNA, proteins and metabolites that are behind the axonal death. The Principal with Principles
3/24/2006
We are honored to announce ALS TDF's summer high school internship program will be named for board member Jenny Huntington. |
